Matches in Nanopublications for { ?s ?p "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742507.RAmAT1h56m-Akc1TheKznnEP6Sx0-vbSlvdiCP6U7Pn7A130_provenance.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.
- assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP882966.RAGV_SvLB_5XmCfiWC12QWJ_fxRXBDqGkYd6EI2Xx2iEU130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882966.RAGV_SvLB_5XmCfiWC12QWJ_fxRXBDqGkYd6EI2Xx2iEU130_provenance.
- NP1032378.RAHA2GYxaPIIE4rzb15WewgqarBBnXmafpCG-hElT5Yd8130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032378.RAHA2GYxaPIIE4rzb15WewgqarBBnXmafpCG-hElT5Yd8130_provenance.
- NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032377.RA1w9GyBLfzXEjIvspcMLilF1ysatojK3QeAsFNagbDJE130_provenance.